查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1679389

乳糜瀉治療市場規模、佔有率、趨勢分析報告：按療法、分銷管道、地區和細分市場預測，2025 年至 2030 年

Celiac Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Vitamins & Minerals, Gluten Degrading Enzymes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

乳糜瀉治療市場趨勢

預計 2024 年全球乳糜瀉治療市場規模將達到 6.902 億美元，2025 年至 2030 年的複合年成長率為 11.7%。

其中最主要的是全球乳糜瀉的盛行率不斷上升。最近的估計表明，大約每 100 個美國人中就有 1 人患有乳糜瀉，但很大一部分人仍未被診斷出來。確診病例的增加是由於人們認知的提高和診斷能力的提高，這直接轉化為對有效治療方法和診斷方法的需求增加。乳糜瀉市場受益於患者數量的不斷成長，推動了藥物創新並擴大了對專業飲食管理的需求。

隨著大眾對乳糜瀉症狀和早期診斷重要性的認知不斷提高，越來越多的患者願意尋求醫療治療和檢測，這有助於確診病例。 Beyond Celiac 在 2023 年進行的一項調查顯示，只有大約 50% 的美國人知道乳糜瀉或麩質敏感性。然而，不斷擴張的無麩質食品產業為患有乳糜瀉的人們提供了多種飲食選擇。此類產品的供應對於確保患者遵守飲食限制起著關鍵作用，從而改善患者健康狀況並促進市場成長。

改進的檢測方法，例如就地檢驗（POCT）的進步，正在促進早期發現和干涉，從而實現更快、更有效的治療。許多國家的政府舉措，例如針對高風險族群的篩檢計劃，進一步支持了市場發展。這些積極措施將增加確診病例的數量，並為患者提供及時的診斷和治療選擇，促進更全面、更積極主動的醫療保健方法。值得注意的是，各國正在實施一項計劃，提高人們對乳糜瀉的認知，改善診斷和治療的機會，強調解決這一日益嚴重的健康問題的努力。

新治療方法的研究和開發有望在未來幾年為乳糜瀉的治療帶來新的發展。抗發炎藥物和治療性疫苗的開發有望增加治療選擇並擴大市場機會。此外，醫療保健支出的增加和研發活動的活性化（特別是新治療方法的研發活動）預計將推動市場擴張。主要企業正在增加對藥品和無麩質產品的投資，表明他們專注於改善患者健康、提高市場滲透率和滿足不斷成長的消費者群體。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 乳糜瀉治療市場變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析—波特五力分析
    • PESTLE分析
    • 管道分析

4. 乳糜瀉治療市場：治療業務分析

  • 2024年和2030年的治療市場佔有率
  • 治療細分儀表板
  • 2018 年至 2030 年按治療類型分類的市場規模、預測和趨勢分析
  • 維生素和礦物質
  • 麩質分解酶
  • 治療（抗發炎藥、抗組織胺等）
  • 其他

5. 乳糜瀉治療市場：通路業務分析

  • 2024年及2030年分銷通路市場佔有率
  • 分銷通路細分儀表板
  • 2018 年至 2030 年按分銷管道分類的市場規模、預測和趨勢分析
  • 醫院藥房
  • 零售藥局
  • 其他

第6章 乳糜瀉治療市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 2018-2030年各國情況
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年各國情況
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 2018-2030年各國情況
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018-2030年各國情況
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2018-2030年各國情況
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Teva Pharmaceutical Industries Ltd.
    • Amgen Inc.
    • Amneal Pharmaceuticals LLC.
    • GLENMARK PHARMACEUTICALS LTD.
    • Takeda Pharmaceutical Company Limited
    • Hikma Pharmaceuticals PLC
    • Viatris Inc.
    • Zydus Pharmaceuticals, Inc.
    • Novartis Pharmaceuticals Corporation
    • BioLineRx
Product Code: GVR-4-68040-488-7

Celiac Disease Treatment Market Trends:

The global celiac disease treatment market size was estimated at USD 690.2 million in 2024 and is projected to grow at a CAGR of 11.7% from 2025 to 2030. Foremost among these is the escalating prevalence of diagnosed celiac disease cases globally. According to recent estimates, approximately 1 in 100 Americans suffers from celiac disease, although a significant proportion of cases remain undiagnosed. This rise in diagnosed instances, attributed to increased awareness and improved diagnostic capabilities, directly translates into a greater demand for effective treatments and diagnostic methodologies. The market benefits from this increasing patient base, driving pharmaceutical innovation and expanding the need for specialized dietary management.

As public knowledge about celiac disease symptoms and the crucial role of early diagnosis continues to grow, individuals are increasingly proactively seeking medical consultations and testing, thereby contributing to the increased identification of cases. Notably, a 2023 survey by Beyond Celiac revealed that only approximately 50% of Americans know anything about celiac disease or gluten sensitivity, indicating a growing awareness gap that needs to be bridged. However, the expanding gluten-free food industry offers a diverse range of dietary options for individuals managing the disease. The availability of these products plays a significant role in patient adherence to dietary restrictions, thereby improving health outcomes and contributing to market growth.

Improvements in detection methods, such as advancements in point-of-care testing (POCT), have facilitated earlier identification and intervention, leading to quicker and more effective treatment. Government initiatives across numerous nations, including screening programs targeting high-risk demographics, further bolster market development. These proactive measures increase the number of diagnosed cases and provide patients with timely access to diagnostics and treatment options, thereby promoting a more comprehensive and proactive healthcare approach. Notably, various countries have implemented programs to raise awareness about celiac disease and enhance access to diagnostics and treatment, underscoring the commitment to addressing this growing health concern.

Ongoing research into new therapeutic modalities assures novel developments in the treatment of celiac disease in the coming years. The development of anti-inflammatory drugs and therapeutic vaccines is expected to enhance treatment options and expand market opportunities. Furthermore, increasing healthcare expenditure and robust R&D activities, particularly in novel treatment alternatives, are poised to drive market expansion. Key players are increasingly investing in drugs and gluten-free products, indicating an emphasis on improving patient health, driving market penetration, and catering to an expanding consumer base.

Global Celiac Disease Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global celiac disease treatment market report based on treatment, distribution channel, and region:

  • Treatment Outlook (Revenue, USD Million, 2018 - 2030)
  • Vitamins & Minerals
  • Gluten Degrading Enzymes
  • Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others)
  • Other Treatments
  • Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Celiac Disease Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis

Chapter 4. Celiac Disease Treatment Market: Treatment Business Analysis

  • 4.1. Treatment Market Share, 2024 & 2030
  • 4.2. Treatment Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
  • 4.4. Vitamins & Minerals
    • 4.4.1. Vitamins & Minerals Market, 2018 - 2030 (USD Million)
  • 4.5. Gluten Degrading Enzymes
    • 4.5.1. Gluten Degrading Enzymes Market, 2018 - 2030 (USD Million)
  • 4.6. Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others)
    • 4.6.1. Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others) Market, 2018 - 2030 (USD Million)
  • 4.7. Other Treatments
    • 4.7.1. Other Treatments Market, 2018 - 2030 (USD Million)

Chapter 5. Celiac Disease Treatment Market: Distribution Channel Business Analysis

  • 5.1. Distribution Channel Market Share, 2024 & 2030
  • 5.2. Distribution Channel Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 5.4. Hospital Pharmacies
    • 5.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.5. Retail Pharmacies
    • 5.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.6. Other Distribution Channels
    • 5.6.1. Other Distribution Channels Market, 2018 - 2030 (USD Million)

Chapter 6. Celiac Disease Treatment Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Teva Pharmaceutical Industries Ltd.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Amgen Inc.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Amneal Pharmaceuticals LLC.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. GLENMARK PHARMACEUTICALS LTD.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Takeda Pharmaceutical Company Limited
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Hikma Pharmaceuticals PLC
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Viatris Inc.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Zydus Pharmaceuticals, Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Novartis Pharmaceuticals Corporation
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. BioLineRx
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global celiac disease treatment market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 5 Global celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 North America celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 8 North America celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 U.S. celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 10 U.S. Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 11 Canada celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 12 Canada celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 13 Mexico celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 14 Mexico celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Europe celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 17 Europe celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 18 UK celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 19 UK Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 20 Germany celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 21 Germany celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 22 France celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 23 France Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24 Italy celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 25 Italy celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 26 Spain celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 27 Spain celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 28 Norway celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 29 Norway Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 Denmark celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 31 Denmark celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 32 Sweden celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 33 Sweden celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 37 Japan celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 38 Japan celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 China celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 40 China celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 41 India celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 42 India celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 43 Australia celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 44 Australia celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 45 South Korea celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 46 South Korea celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 47 Thailand celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 48 Thailand celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 49 Latin America celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 51 Latin America celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52 Brazil celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 53 Brazil celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 54 Argentina celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 55 Argentina celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 59 South Africa celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 60 South Africa celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 63 UAE celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 64 UAE celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 65 Kuwait celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 66 Kuwait celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Celiac disease treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Treatment and distribution channel outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Celiac disease treatment market dynamics
  • Fig. 12 Celiac disease treatment market: Porter's five forces analysis
  • Fig. 13 Celiac disease treatment market: PESTLE analysis
  • Fig. 14 Celiac disease treatment market: Treatment segment dashboard
  • Fig. 15 Celiac disease treatment market: Treatment market share analysis, 2024 & 2030
  • Fig. 16 Vitamins & minerals market, 2018 - 2030 (USD Million)
  • Fig. 17 Gluten degrading enzymes market, 2018 - 2030 (USD Million)
  • Fig. 18 Symptomatic treatment (anti-inflammatory drugs, antihistamines, others) market, 2018 - 2030 (USD Million)
  • Fig. 19 Other treatments market, 2018 - 2030 (USD Million)
  • Fig. 20 Celiac disease treatment market: Distribution channel segment dashboard
  • Fig. 21 Celiac disease treatment market: Distribution channel market share analysis, 2024 & 2030
  • Fig. 22 Hospital pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 23 Retail pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 24 Other distribution channels market, 2018 - 2030 (USD Million)
  • Fig. 25 Celiac disease treatment market revenue, by region
  • Fig. 26 Regional marketplace: Key takeaways
  • Fig. 27 Regional marketplace: Key takeaways
  • Fig. 28 North America celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. country dynamics
  • Fig. 30 U.S. celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 31 Canada country dynamics
  • Fig. 32 Canada celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico country dynamics
  • Fig. 34 Mexico celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 36 UK country dynamics
  • Fig. 37 UK celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany country dynamics
  • Fig. 39 Germany celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 40 France country dynamics
  • Fig. 41 France celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 42 Italy country dynamics
  • Fig. 43 Italy celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain country dynamics
  • Fig. 45 Spain celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 46 Norway country dynamics
  • Fig. 47 Norway celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden country dynamics
  • Fig. 49 Sweden celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark country dynamics
  • Fig. 51 Denmark celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan country dynamics
  • Fig. 54 Japan celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 55 China country dynamics
  • Fig. 56 China celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 57 India country dynamics
  • Fig. 58 India celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 59 Australia country dynamics
  • Fig. 60 Australia celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 61 South Korea country dynamics
  • Fig. 62 South Korea celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand country dynamics
  • Fig. 64 Thailand celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil country dynamics
  • Fig. 67 Brazil celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina country dynamics
  • Fig. 69 Argentina celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 70 MEA celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa country dynamics
  • Fig. 72 South Africa celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 73 Saudi Arabia country dynamics
  • Fig. 74 Saudi Arabia celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 75 UAE country dynamics
  • Fig. 76 UAE celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 77 Kuwait country dynamics
  • Fig. 78 Kuwait celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 79 Company categorization
  • Fig. 80 Company market position analysis
  • Fig. 81 Strategic framework